Works matching IS 17562856 AND DT 2024 AND VI 17

Results: 102
    1

    Eculizumab in thymoma-associated myasthenia gravis: a real-world cohort study.

    Published in:
    Therapeutic Advances in Neurological Disorders, 2024, v. 17, p. 1, doi. 10.1177/17562864241309431
    By:
    • Jin, Lei;
    • He, Dingxian;
    • Zeng, Quantao;
    • Tan, Song;
    • Shi, Jianquan;
    • Liu, Ying;
    • Zou, Zhangyu;
    • Song, Jie;
    • Yan, Chong;
    • Huan, Xiao;
    • Wang, Yuan;
    • Yang, Lei;
    • Xi, Jianying;
    • Wu, Zongtai;
    • Liu, Ziqi;
    • Zheng, Jianming;
    • Zhao, Chongbo;
    • Chu, Xianglin;
    • Luo, Sushan
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14

    Beyond lines of treatment: embracing early high-efficacy disease-modifying treatments for multiple sclerosis management.

    Published in:
    Therapeutic Advances in Neurological Disorders, 2024, v. 17, p. 1, doi. 10.1177/17562864241284372
    By:
    • Oreja-Guevara, Celia;
    • Martínez-Yélamos, Sergio;
    • Eichau, Sara;
    • Llaneza, Miguel Ángel;
    • Martín-Martínez, Jesús;
    • Peña-Martínez, Joaquín;
    • Meca-Lallana, Virginia;
    • Alonso-Torres, Ana María;
    • Moral-Torres, Ester;
    • Río, Jordi;
    • Calles, Carmen;
    • Ares-Luque, Adrián;
    • Ramió-Torrentà, Lluís;
    • Marzo-Sola, María Eugenia;
    • Prieto, José María;
    • Martínez-Ginés, María Luisa;
    • Arroyo, Rafael;
    • Otano-Martínez, María Ángeles;
    • Brieva-Ruiz, Luis;
    • Gómez-Gutiérrez, Montserrat
    Publication type:
    Article
    15
    16
    17
    18

    Identification of alemtuzumab-suitable multiple sclerosis patients in Slovakia and sequencing of post-alemtuzumab immunomodulatory treatment.

    Published in:
    Therapeutic Advances in Neurological Disorders, 2024, v. 17, p. 1, doi. 10.1177/17562864241285556
    By:
    • Kantorová, Ema;
    • Vítková, Marianna;
    • Martiníková, Martina;
    • Cimprichová, Andrea;
    • Fedicˇová, Miriam;
    • Kovácˇová, Slavomíra;
    • Mako, Miroslav;
    • Cisár, Juraj;
    • Hancˇinová, Viera;
    • Szilasiová, Jarmila;
    • Koleda, Peter;
    • RoháIˇová, Jana;
    • Polóniová, Jana;
    • Karlík, Martin;
    • Slezáková, Darina;
    • Klímová, Eleonóra;
    • Maciak, Matúš;
    • Kurcˇa, Egon;
    • Hnilicová, Petra
    Publication type:
    Article
    19
    20
    21
    22
    23
    24

    Risk of major adverse cardiovascular events and all-cause mortality under treatment with GLP-1 RAs or the dual GIP/GLP-1 receptor agonist tirzepatide in overweight or obese adults without diabetes: a systematic review and meta-analysis.

    Published in:
    Therapeutic Advances in Neurological Disorders, 2024, v. 17, p. 1, doi. 10.1177/17562864241281903
    By:
    • Stefanou, Maria-Ioanna;
    • Palaiodimou, Lina;
    • Theodorou, Aikaterini;
    • Safouris, Apostolos;
    • Fischer, Urs;
    • Kelly, Peter J.;
    • Dawson, Jesse;
    • Katan, Mira;
    • Katsanos, Aristeidis H.;
    • Lambadiari, Vaia;
    • Giannopoulos, Sotirios;
    • Alexandrov, Andrei V.;
    • Siasos, Gerasimos;
    • Tsivgoulis, Georgios
    Publication type:
    Article
    25

    Maintenance of zilucoplan efficacy in patients with generalised myasthenia gravis up to 24 weeks: a model-informed analysis.

    Published in:
    Therapeutic Advances in Neurological Disorders, 2024, v. 17, p. 1, doi. 10.1177/17562864241279125
    By:
    • de la Borderie, Guillemette;
    • Chimits, Damien;
    • Boroojerdi, Babak;
    • Brock, Melissa;
    • Duda, Petra W.;
    • Grimson, Fiona;
    • Mahoney, Paul;
    • Strimenopoulou, Foteini;
    • Cutter, Gary;
    • Aban, Inmaculada;
    • Brauner, Susanna;
    • Petersson, Malin;
    • Howard Jr, James F.;
    • Bennett, Nathan
    Publication type:
    Article
    26
    27
    28

    The impact of COVID-19 infection on multiple sclerosis disease course across 12 countries: a propensity-score-matched cohort study.

    Published in:
    Therapeutic Advances in Neurological Disorders, 2024, v. 17, p. 1, doi. 10.1177/17562864241278496
    By:
    • Levitz, David;
    • Chao Foong, Yi;
    • Sanfilippo, Paul;
    • Spelman, Tim;
    • Rath, Louise;
    • Roldan, Angie;
    • Lal, Anoushka;
    • Monif, Mastura;
    • Jokubaitis, Vilija;
    • Ozakbas, Serkan;
    • Alroughani, Raed;
    • Boz, Cavit;
    • Terzi, Murat;
    • Kalincik, Tomas;
    • Blanco, Yolanda;
    • Foschi, Matteo;
    • Surcinelli, Andrea;
    • Buzzard, Katherine;
    • Skibina, Olga;
    • Laureys, Guy
    Publication type:
    Article
    29

    Long-term analysis of infections and associated risk factors in patients with multiple sclerosis treated with ocrelizumab: pooled analysis of 13 interventional clinical trials.

    Published in:
    Therapeutic Advances in Neurological Disorders, 2024, v. 17, p. 1, doi. 10.1177/17562864241277736
    By:
    • Derfuss, Tobias;
    • Bermel, Robert;
    • Lin, Chien-Ju;
    • Hauser, Stephen L.;
    • Kappos, Ludwig;
    • Vollmer, Timothy;
    • Comi, Giancarlo;
    • Giovannoni, Gavin;
    • Hartung, Hans-Peter;
    • Weber, Martin S.;
    • Wang, Jianmei;
    • Jessop, Nikki;
    • Chognot, Cathy;
    • Craveiro, Licinio;
    • Bar-Or, Amit
    Publication type:
    Article
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41

    Efficacy and safety of rozanolixizumab in patients with muscle-specific tyrosine kinase autoantibody-positive generalised myasthenia gravis: a subgroup analysis of the randomised, double-blind, placebo-controlled, adaptive phase III MycarinG study.

    Published in:
    Therapeutic Advances in Neurological Disorders, 2024, v. 17, p. 1, doi. 10.1177/17562864241273036
    By:
    • Habib, Ali A.;
    • Sacconi, Sabrina;
    • Antonini, Giovanni;
    • Cortés-Vicente, Elena;
    • Grosskreutz, Julian;
    • Mahuwala, Zabeen K.;
    • Mantegazza, Renato;
    • Pascuzzi, Robert M.;
    • Utsugisawa, Kimiaki;
    • Vissing, John;
    • Vu, Tuan;
    • Wiendl, Heinz;
    • Boehnlein, Marion;
    • Greve, Bernhard;
    • Woltering, Franz;
    • Bril, Vera
    Publication type:
    Article
    42
    43
    44

    The association of vagal atrophy with parameters of autonomic function in multiple system atrophy and progressive supranuclear palsy.

    Published in:
    Therapeutic Advances in Neurological Disorders, 2024, v. 17, p. 1, doi. 10.1177/17562864241267300
    By:
    • Kleinz, Teresa;
    • Scholz, Leonard;
    • Huckemann, Sophie;
    • Rohmann, Rachel;
    • Kühn, Eva;
    • Averdunk, Paulina;
    • Kools, Saskia;
    • Hilker, Lovis;
    • Bieber, Antonia;
    • Müller, Katharina;
    • Motte, Jeremias;
    • Fisse, Anna-Lena;
    • Schneider-Gold, Christiane;
    • Gold, Ralf;
    • Kwon, Eun Hae;
    • Tönges, Lars;
    • Pitarokoili, Kalliopi
    Publication type:
    Article
    45
    46
    47
    48
    49

    Pattern of pareses in 5q-spinal muscular atrophy.

    Published in:
    Therapeutic Advances in Neurological Disorders, 2024, v. 17, p. 1, doi. 10.1177/17562864241263420
    By:
    • Uzelac, Zeljko;
    • Schwäble, Beate;
    • Dorst, Johannes;
    • Rosenbohm, Angela;
    • Wollinsky, Kurt;
    • Wurster, Claudia D.;
    • Steinbreier, Janna S.;
    • Ludolph, Albert C.
    Publication type:
    Article
    50